Literature DB >> 6223734

Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

S Gupta, S M Fikrig, E Mariano, Q Quazi.   

Abstract

Peripheral blood from 21 non-institutionalized children with Down's syndrome (DS) and 21 age and sex matched simultaneously studied healthy controls, was analysed for monoclonal antibody defined T cells and T cell subsets, using a fluorescence activated cell sorter, and the autologous (AMLR) and allogeneic mixed lymphocyte reaction (MLR). Total T cells (9.6+), OKT4+ (helper/inducer phenotype) and anti-Tac+ (activated T) cells were present in comparable proportions to that observed in the control group. In contrast, the proportion of OKT8+ (suppressor/cytotoxic phenotype) cells were significantly (P less than 0.05) decreased when compared to healthy controls. The proliferative response in the AMLR and MLR were comparable to control group. The significance of these results are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223734      PMCID: PMC1535525     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

2.  T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects.

Authors:  C Franceschi; F Licastro; P Paolucci; M Masi; S Cavicchi; M Zannotti
Journal:  J Ment Defic Res       Date:  1978-09

3.  Immunity in Down's syndrome.

Authors:  G R Burgio; A G Ugazio
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

4.  Immunologic characteristics of Down's syndrome.

Authors:  M E Gershwin; F M Crinella; J J Castles; J K Trent
Journal:  J Ment Defic Res       Date:  1977-12

5.  Hypersensitivity of lymphocytes in Down's syndrome shown by mixed leukocyte culture experiments.

Authors:  M Sasaki; Y Obara
Journal:  Nature       Date:  1969-05-10       Impact factor: 49.962

6.  Susceptibility to leukemia: immunologic factors in Down's syndrome.

Authors:  A I Sutnick; W T London; B S Blumberg; B J Gerstley
Journal:  J Natl Cancer Inst       Date:  1971-11       Impact factor: 13.506

7.  T-lymphocyte deficiency in Down syndrome.

Authors:  A G Ugazio; R Maccario; M Duse; G R Burgio
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

8.  Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.

Authors:  G R Burgio; A G Ugazio; L Nespoli; A F Marcioni; A M Bottelli; F Pasquali
Journal:  Eur J Immunol       Date:  1975-09       Impact factor: 5.532

9.  Thymic deficiency in Down's syndrome.

Authors:  S Levin; M Schlesinger; Z Handzel; T Hahn; Y Altman; B Czernobilsky; J Boss
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

10.  Stress deficiency of the T-lymphocyte system exemplified by Down syndrome.

Authors:  S Whittingham; D B Pitt; D L Sharma; I R Mackay
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

View more
  5 in total

1.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  T cell response to anti-CD3 antibody in Down's syndrome.

Authors:  A Bertotto; C Arcangeli; S Crupi; I Marinelli; R Gerli; R Vaccaro
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

3.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Immunological studies in patients with isolated growth hormone deficiency.

Authors:  S Gupta; S M Fikrig; M S Noval
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.